Ozempic Philippines Price 2026

Each pen lasts 4 weekly injections. Monthly cost = pen price × ~1.0 (assuming weekly dosing at the labeled dose). For dose escalation, you usually need different SKUs per month.

These are out-of-pocket costs at the drugstore-chain listings above. PhilHealth does not cover GLP-1s for weight loss; HMOs (Maxicare, Intellicare, Medicard) cover only the diabetes indication and require pre-authorization with HbA1c documentation above 6.5%. Note the shape of that table: branded semaglutide costs less per year than most buyers here expect, while tirzepatide at the top strengths is the expensive end of the shelf by a wide margin.

Hospital pharmacies(St. Luke's BGC, Makati Med, The Medical City, Asian Hospital) carry GLP-1s reliably because the prescribing endocrinologists write directly into hospital pharmacy queues. They do not publish their pen prices, so this page quotes none for them. Expect to pay at or above the chain listings in section 02, and ask for the figure before the pharmacist rings it up.

Retail chains (Watsons, Rose Pharmacy, Southstar, MedsGo) are the published-price baseline, and they are the only Philippine sources this page will quote. They also ration: Manila Bulletin reported branch limits of about two pens per dosage per month on Ozempic in June 2026, and every Mounjaro strength checked at Watsons was restricted to click and collect rather than delivery.

Practical pattern: fill the first prescription at the hospital pharmacy on the day of your endocrinology consult, because it removes both the separate trip and the stockout risk. Refill against the chain listings once you know what the pen should cost, and confirm stock in the same call as the quote.

Research-grade semaglutide and tirzepatide sold by international suppliers run roughly 2–4x cheaper than the pharmacy pen on a cost-per-dose basis. That multiple is a good deal smaller than the 5–6x this page used to claim, because the branded pen prices it was measured against were roughly double the real ones. The molecule is identical; what you lose is FDA Philippines registration, audited cold-chain, pharmacy callback support, and a prescription written by a licensed Philippine physician.

Note which way the multiplier runs. On semaglutide it shrinks as the dose rises, to about two times at the 1mg and 2.4mg tiers, because the pen is priced by the box while a vial is priced by the milligram. On tirzepatide it grows, to about four times at 10mg, because the Mounjaro price ladder climbs faster than the dose does. Grey-market pricing is also highly supplier-dependent. Always require third-party COA per batch, cold-chain insulated packaging, and your own baseline labs before starting any cycle. See our PH supplier guide.

The correction that produced this section. Until August 2026 this page carried a set of personal receipts quoting roughly ₱14,200 for an Ozempic 0.5mg pen and attributing it to named Mercury Drug branches. The pen is ₱7,650, confirmed at Watsons, Rose Pharmacy and Southstar simultaneously, and Mercury Drug published none of those figures. The receipts are gone rather than adjusted, because a receipt you cannot produce is not evidence.

What the pen actually costs to run. At ₱7,650 an Ozempic 0.5mg pen is about $137 a month and roughly $34 a weekly dose. At ₱8,734 the 1mg pen is about $156 a month and $39 a dose. Those are the numbers to hold in your head walking into a counter, and a quote far above them is worth questioning before you pay it.

Where the stockout pattern actually bites. Mounjaro is the harder product to obtain here, not the more expensive semaglutide pens. Every Watsons Mounjaro strength checked was click and collect only, Southstar listed the 5mg KwikPen as available soon rather than in stock, and Ozempic itself has been rationed at branch level. Switching molecule because a shelf was empty is a different decision from switching because a prescriber recommended it, and only one of those belongs in a treatment plan.

Annual math, corrected. Branded Mounjaro 10mg at the Watsons listing is about $4,918 a year. Research-grade tirzepatide at 10mg weekly runs about $1,150 a year, plus four quarterly private lab panels at roughly $380 a year, so about $1,530 all-in. The gap is real, but it is a gap against a prescription medicine dispensed by a registered pharmacy, and closing it means taking the diligence work on yourself.